Caron John H

SEC source: 0001628280-26-064226 · wk-form4_1790884876.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,445

F1 · shares: Restricted Stock received for Q3 2026 director fees valued at $15,000 based on the closing market price of $2.51 on the grant date of September 30, 2026. Award vests immediately at the grant date.

SEC source: 0001628280-26-046517 · wk-form4_1782936278.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,469

F1 · shares: Restricted Stock received for Q2 2026 director fees valued at $15,000 based on the closing market price of $3.70 on the grant date of June 30, 2026. Award vests immediately at the grant date.

SEC source: 0001521868-26-000004 · wk-form4_1775074108.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,415

F1 · shares: Restricted Stock received for Q1 2026 director fees valued at $15,000 based on the closing market price of $3.5100 on the grant date of March 31, 2026. Award vests immediately at the grant date.

SEC source: 0001521868-26-000002 · wk-form4_1767391239.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,566

F1 · shares: Restricted Stock received for Q4 2025 director fees valued at $15,000 based on the closing market price of $4.3800 on the grant date of December 31, 2025. Award vests on the grant date.

SEC source: 0001521868-25-000003 · wk-form4_1759349200.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,141

F1 · shares: Restricted Stock received for Q3 2025 director fees valued at $15,000 based on the closing market price of $3.7200 on the grant date of September 30, 2025. Award vests on the grant date.

F1 · price: Restricted Stock received for Q3 2025 director fees valued at $15,000 based on the closing market price of $3.7200 on the grant date of September 30, 2025. Award vests on the grant date.

SEC source: 0001495231-25-000138 · wk-form4_1751401804.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 98,109

F1 · shares: Restricted Stock received for Q2 2025 director fees valued at $15,000 based on the closing market price of $2.5500 on the grant date of June 30, 2025. Award vests on the grant date.

F1 · price: Restricted Stock received for Q2 2025 director fees valued at $15,000 based on the closing market price of $2.5500 on the grant date of June 30, 2025. Award vests on the grant date.

SEC source: 0001495231-25-000059 · wk-form4_1743538369.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,227

F1 · shares: Restricted Stock received for Q1 2025 director fees valued at $15,000 based on the closing market price of $2.1000 on the grant date of March 31, 2025. Award vests on the grant date.

F1 · price: Restricted Stock received for Q1 2025 director fees valued at $15,000 based on the closing market price of $2.1000 on the grant date of March 31, 2025. Award vests on the grant date.

SEC source: 0001495231-25-000010 · wk-form4_1735857163.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,084

F1 · shares: Restricted Stock received for Q4 2024 director fees valued at $15,000 based on the closing market price of $2.7500 on the grant date of December 31, 2024. Award vests on the grant date.

F1 · price: Restricted Stock received for Q4 2024 director fees valued at $15,000 based on the closing market price of $2.7500 on the grant date of December 31, 2024. Award vests on the grant date.

SEC source: 0001495231-24-000203 · wk-form4_1727813283.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,629

F1 · shares: Restricted Stock received for Q3 2024 director fees valued at $15,000 based on the closing market price of $2.7500 on the grant date of September 30, 2024. Award vests on the grant date.

F1 · price: Restricted Stock received for Q3 2024 director fees valued at $15,000 based on the closing market price of $2.7500 on the grant date of September 30, 2024. Award vests on the grant date.

SEC source: 0001495231-24-000131 · wk-form4_1719864696.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,174

F1 · shares: Restricted Stock received for Q2 2024 director fees valued at $15,000 based on the closing market price of $2.3500 on the grant date of June 30, 2024. Award vests on the grant date.

F1 · price: Restricted Stock received for Q2 2024 director fees valued at $15,000 based on the closing market price of $2.3500 on the grant date of June 30, 2024. Award vests on the grant date.

SEC source: 0001495231-24-000054 · wk-form4_1712090228.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,791

F1 · shares: Restricted Stock received for Q1 2024 director fees valued at $15,000 based on the closing market price of $2.3100 on the grant date of March 31, 2024. Award vests on the grant date.

F1 · price: Restricted Stock received for Q1 2024 director fees valued at $15,000 based on the closing market price of $2.3100 on the grant date of March 31, 2024. Award vests on the grant date.

SEC source: 0001495231-24-000014 · wk-form4_1704311364.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,297

F1 · shares: Restricted Stock received for Q4 2023 director fees valued at $15,000 based on the closing market price of $2.0100 on the grant date of December 31, 2023. Award vests on the grant date.

F1 · price: Restricted Stock received for Q4 2023 director fees valued at $15,000 based on the closing market price of $2.0100 on the grant date of December 31, 2023. Award vests on the grant date.

SEC source: 0001495231-23-000184 · wk-form4_1696281571.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,834

F1 · shares: Restricted Stock received for Q3 2023 director fees valued at $15,000 based on the closing market price of $2.1800 on the grant date of September 30, 2023. Award vests on the grant date.

F1 · price: Restricted Stock received for Q3 2023 director fees valued at $15,000 based on the closing market price of $2.1800 on the grant date of September 30, 2023. Award vests on the grant date.

F2 · balance_after: On June 16, 2023 the Issuer effected a 1-for-4 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001495231-23-000110 · wk-form4_1688414031.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,953

F1 · shares: Restricted Stock received for Q2 2023 director fees valued at $15,000 based on the closing market price of $2.4200 on the grant date of June 30, 2023. Award vests on the grant date.

F1 · price: Restricted Stock received for Q2 2023 director fees valued at $15,000 based on the closing market price of $2.4200 on the grant date of June 30, 2023. Award vests on the grant date.

F2 · balance_after: On June 16, 2023 the Issuer effected a 1-for-4 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001495231-23-000043 · wf-form4_168055346661054.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 163,017

F1 · shares: Restricted Stock received for Q1 2023 director fees valued at $15,000 based on the closing market price of $0.6509 on the grant date of March 31, 2023. Award vests on the grant date.

F1 · price: Restricted Stock received for Q1 2023 director fees valued at $15,000 based on the closing market price of $0.6509 on the grant date of March 31, 2023. Award vests on the grant date.

SEC source: 0001495231-22-000015 · wf-form4_164383606890637.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,972

F1 · shares: Restricted Stock received for 2022 director fees valued at $25,000 based on the closing market price of $1.18 on the grant date. Award vests in equal monthly installments of approximately 1766 shares on the last day of each month from January through December 31, 2022. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · price: Restricted Stock received for 2022 director fees valued at $25,000 based on the closing market price of $1.18 on the grant date. Award vests in equal monthly installments of approximately 1766 shares on the last day of each month from January through December 31, 2022. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

SEC source: 0001495231-21-000028 · wf-form4_161218511728367.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,786

F1 · shares: Restricted Stock received for 2021 director fees valued at $25,000 based on the closing market price of $4.79 on the grant date. Award vests in equal monthly installments of approximately 435 shares on the last day of each month from January through December 31, 2021. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · price: Restricted Stock received for 2021 director fees valued at $25,000 based on the closing market price of $4.79 on the grant date. Award vests in equal monthly installments of approximately 435 shares on the last day of each month from January through December 31, 2021. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

SEC source: 0001495231-20-000012 · wf-form4_158074315979339.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,567

F1 · shares: Restricted Stock received for 2020 director fees valued at $25,000 based on the closing market price of $0.32 on the grant date. Award vests in equal monthly installments of approximately 6,510 shares on the last day of each month from January through December 31, 2020. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · price: Restricted Stock received for 2020 director fees valued at $25,000 based on the closing market price of $0.32 on the grant date. Award vests in equal monthly installments of approximately 6,510 shares on the last day of each month from January through December 31, 2020. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

SEC source: 0001495231-19-000015 · wf-form4_154927866387848.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,442

F1 · shares: Restricted Stock received for 2019 director fees valued at $25,000 based on the closing market price of $1.69 on the grant date. Award vests in equal monthly installments of approximately 1,233 shares on the last day of each month from January through December 31, 2019. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · price: Restricted Stock received for 2019 director fees valued at $25,000 based on the closing market price of $1.69 on the grant date. Award vests in equal monthly installments of approximately 1,233 shares on the last day of each month from January through December 31, 2019. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

SEC source: 0001495231-18-000016 · wf-form4_151753812503842.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,649

F1 · security: Restricted Stock received for 2018 director fees valued at $25,000 based on the closing market price of $4.13 on the grant date. Award vests in equal monthly installments on the last day of each month from January through December 31, 2018. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · shares: Restricted Stock received for 2018 director fees valued at $25,000 based on the closing market price of $4.13 on the grant date. Award vests in equal monthly installments on the last day of each month from January through December 31, 2018. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · price: Restricted Stock received for 2018 director fees valued at $25,000 based on the closing market price of $4.13 on the grant date. Award vests in equal monthly installments on the last day of each month from January through December 31, 2018. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

SEC source: 0001495231-17-000099 · wf-form4_150962915276589.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,596

F1 · security: Restricted Stock received for Q4 2017 director fees valued at $6,250 based on the closing market price of $3.33 on the grant date. Award vests in equal monthly installments of approximately 626 shares on October 31, 2017, November 30, 2017 and December 31, 2017. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · shares: Restricted Stock received for Q4 2017 director fees valued at $6,250 based on the closing market price of $3.33 on the grant date. Award vests in equal monthly installments of approximately 626 shares on October 31, 2017, November 30, 2017 and December 31, 2017. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · price: Restricted Stock received for Q4 2017 director fees valued at $6,250 based on the closing market price of $3.33 on the grant date. Award vests in equal monthly installments of approximately 626 shares on October 31, 2017, November 30, 2017 and December 31, 2017. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

SEC source: 0001495231-17-000072 · wf-form4_150179241722023.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,719

F1 · security: Restricted Stock received for Q3 2017 director fees valued at $6,250 based on the closing market price of $1.87 on the grant date. Award vests in equal monthly installments of 1,114 shares on July 31, 2017, August 31, 2017 and September 30, 2017. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · shares: Restricted Stock received for Q3 2017 director fees valued at $6,250 based on the closing market price of $1.87 on the grant date. Award vests in equal monthly installments of 1,114 shares on July 31, 2017, August 31, 2017 and September 30, 2017. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · price: Restricted Stock received for Q3 2017 director fees valued at $6,250 based on the closing market price of $1.87 on the grant date. Award vests in equal monthly installments of 1,114 shares on July 31, 2017, August 31, 2017 and September 30, 2017. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

SEC source: 0001495231-17-000041 · wf-form4_149367491084736.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,377

F1 · security: Restricted Stock received for Q2 2017 director fees valued at $6,250 based on the closing market price of $3.66 on the last trading day prior to the grant date. Award vests as to 569 shares on April 30, 2017, 570 shares on May 31, 2017 and 569 shares on June 30, 2017. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · shares: Restricted Stock received for Q2 2017 director fees valued at $6,250 based on the closing market price of $3.66 on the last trading day prior to the grant date. Award vests as to 569 shares on April 30, 2017, 570 shares on May 31, 2017 and 569 shares on June 30, 2017. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · price: Restricted Stock received for Q2 2017 director fees valued at $6,250 based on the closing market price of $3.66 on the last trading day prior to the grant date. Award vests as to 569 shares on April 30, 2017, 570 shares on May 31, 2017 and 569 shares on June 30, 2017. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

SEC source: 0001495231-17-000012 · wf-form4_148606649293263.xml · nonDerivative · entry 1

Caron John H · CIK 0001521868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,669

F1 · security: Restricted Stock received for Q1 2017 director fees valued at $6,250 based on the closing market price of $4.38 on the grant date. Award vests as to 475 shares on January 31, 2017, 476 shares on February 28, 2017 and 476 shares on March 31, 2017. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · shares: Restricted Stock received for Q1 2017 director fees valued at $6,250 based on the closing market price of $4.38 on the grant date. Award vests as to 475 shares on January 31, 2017, 476 shares on February 28, 2017 and 476 shares on March 31, 2017. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.

F1 · price: Restricted Stock received for Q1 2017 director fees valued at $6,250 based on the closing market price of $4.38 on the grant date. Award vests as to 475 shares on January 31, 2017, 476 shares on February 28, 2017 and 476 shares on March 31, 2017. In the event the Reporting Person no longer serves as a director at each vesting date, any unvested shares will be forfeited to the Issuer.